FierceBiotechOriginal article
{"a":[{"_":"Boston Scientific cuts guidance again after unveiling restructuring plan","$":{"href":"/medtech/boston-scientific-fresh-cost-savings-drive-plan-cuts-guidance-again","hreflang":"en"}}]}
EarningsNegative
AI Analysis
Summary
Boston Scientific is cutting its financial guidance for the second quarter in a row as part of a restructuring plan aimed at cost savings. The company faces a challenging six-month period ahead.
Financial Highlights
Guidance
reduced
Importance:5/10
Sentiment:
-0.75
guidance cutrestructuringcost savingsearnings
Related Companies
Read the original article
Published by FierceBiotech on July 30, 2026 3:55 AM
